Zhongming Qiu
Zhongming Qiu
Explore linked clinical trials.11 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study on Efficacy Evaluation of Ripertamab in the Treatment of Neuromyelitis Optica Spectrum Disorders | Neuromyelitis Optica Spectrum Disease (NMOSD); Ripertamab | Not yet recruiting | Phase 1 / Phase 2 | 2026-09-21 | NCT07685678 | |
| An Exploratory Study of Obinutuzumab β in the Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy | Chronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, autoimmune disease, autoimmune disorder of the nervous system, chronic inflammatory demyelinating polyradiculoneuropathy, demyelinating disease, immune system disorder, nervous system disorder, neuromuscular disease, peripheral nervous system disorder, polyneuropathy, polyradiculoneuropathy | Not yet recruiting | Phase 1 / Phase 2 | 2026-07-10 | NCT07696377 | |
| Ripertamab for the Treatment of Myasthenia Gravis | Neoplasms by Site, Paraneoplastic Syndromes, Nervous System, autoimmune disease, autoimmune disorder of the nervous system, immune system disorder, myasthenia gravis, neoplasm, nervous system disorder, neurodegenerative disease, neuromuscular disease, neuromuscular junction disease, paraneoplastic syndrome | Not yet recruiting | Phase 1 / Phase 2 | 2026-01-28 | NCT07372807 | |
| TELITACICEPT IN INFLAMMATORY MYOPATHIES(TELITACICEPT-IM) | muscle tissue disorder, musculoskeletal system disorder, myositis disease, nervous system disorder, neuromuscular disease | Not yet recruiting | Phase 2 / Phase 3 | 2026-01-21 | NCT07355257 | |
| Prospective Registry of Endovascular Thrombectomy for eXtra-Large Ischemic Stroke | brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, ischemic stroke, nervous system disorder, stroke disorder, vascular disorder | Recruiting | Not stated | 2025-12-31 | NCT06210633 | |
| Endovascular Treatment for eXtra-Large Ischemic Stroke | Acute Ischemic Stroke, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, ischemic stroke, nervous system disorder, stroke disorder, vascular disorder | Recruiting | Not applicable | 2025-12-26 | NCT06388148 | |
| Efgartigimod for the Treatment of Guillain-Barré Syndrome | Chronic Disease, Disease Attributes, Guillain-Barre syndrome, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Post-Infectious Disorders, autoimmune disease, autoimmune disorder of the nervous system, demyelinating disease, immune system disorder, nervous system disorder, neuromuscular disease, peripheral nervous system disorder, polyneuropathy, polyradiculoneuropathy | Not yet recruiting | Phase 2 / Phase 3 | 2025-03-20 | NCT06885762 | |
| Ripertamab for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy | Chronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, autoimmune disease, autoimmune disorder of the nervous system, chronic inflammatory demyelinating polyradiculoneuropathy, demyelinating disease, immune system disorder, nervous system disorder, neuromuscular disease, peripheral nervous system disorder, polyneuropathy, polyradiculoneuropathy | Not yet recruiting | Phase 3 | 2025-03-05 | NCT06858722 | |
| Blinatumomab in Refractory Myasthenia Gravis (BLINA-MG) | Myasthaenia Gravis | Not yet recruiting | Phase 2 / Phase 3 | 2024-11-12 | NCT06684184 | |
| Tirofiban for Successful Endovascular Stroke Thrombectomy | Acute Ischemic Stroke, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, ischemic stroke, nervous system disorder, stroke disorder, vascular disorder | Not yet recruiting | Phase 2 / Phase 3 | 2024-05-16 | NCT06373042 | |
| DTI-guided Minimally Invasive Hematoma Evacuation for Intracerebral Hemorrhage | Hemorrhage, Intracranial Hemorrhages, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, hemorrhagic stroke, intracerebral hemorrhage, nervous system disorder, stroke disorder, vascular disorder | Recruiting | Not applicable | 2023-09-13 | NCT05891509 |